Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Proguanil 25mg / Atovaquone 62.5mg tablets |
| BNF code | 0504010U0AAABAB |
| Virtual Therapeutic Moiety | Proguanil + Atovaquone |
| Date identifier became valid | 27 May 2021 |
| Previous product identifier | 377213008 |
| Basis of preferred name | Other |
| Date of name applicability | 27 Apr 2010 |
| Previous name | Atovaquone 62.5mg / Proguanil 25mg tablets |
| Basis of previous name | Other |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Proguanil hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 25.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Atovaquone |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 62.500 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Malarone Paediatric 62.5mg/25mg tablets (GlaxoSmithKline UK Ltd) | |
| Proguanil 25mg / Atovaquone 62.5mg tablets (Alliance Healthcare (Distribution) Ltd) | |
| Proguanil 25mg / Atovaquone 62.5mg tablets (Amarox Ltd) | |
| Virtual Medicinal Product Packs | |
| Proguanil 25mg / Atovaquone 62.5mg tablets 12 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.